Pantethine prevents murine systemic sclerosis through the inhibition of microparticle shedding

Arthritis and Rheumatology

Volumn 67, Issue 7, 2015, Pages 1881-1890

  Kavian, Niloufar ^a   Marut, Wioleta ^a   Servettaz, Amélie ^a,b   Nicco, Carole ^a   Chéreau, Christiane ^a   Lemaréchal, Hervé ^c   Guilpain, Philippe ^d   Chimini, Giovanna ^e   Galland, Franck ^e   Weill, Bernard ^a   Naquet, Philippe ^e   Batteux, Frédéric ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b SERVICE DE DERMATOLOGIE   (France)

^c Institut Cochin   (France)

^d UNIV MONTPELLIER   (France)

^e CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ADVANCED OXIDATION PROTEIN PRODUCT; CATALASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUTATHIONE; HYDROGEN PEROXIDE; NITRIC OXIDE; PANTETHINE; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1; ABCA1 PROTEIN, MOUSE; BLEOMYCIN; HYPOCHLOROUS ACID; PANTETHEINE;

3T3 CELL LINE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CELL DAMAGE; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIAL MICROPARTICLE; ENDOTHELIAL MICROPARTICLE SHEDDING; EX VIVO STUDY; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG FIBROSIS; MOUSE; NITROSATIVE STRESS; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; SKIN FIBROSIS; SKINFOLD THICKNESS; SYSTEMIC SCLEROSIS; UMBILICAL VEIN ENDOTHELIAL CELL; ANALOGS AND DERIVATIVES; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CHEMICALLY INDUCED; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; ENDOTHELIUM CELL; FEMALE; GENETICS; HOMEOSTASIS; INTRADERMAL DRUG ADMINISTRATION; KNOCKOUT MOUSE; MEMBRANE MICROPARTICLE; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; SCLERODERMA, SYSTEMIC; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; ATP BINDING CASSETTE TRANSPORTER 1; BLEOMYCIN; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FEMALE; FIBROBLASTS; HOMEOSTASIS; HYPOCHLOROUS ACID; IN VITRO TECHNIQUES; INJECTIONS, INTRADERMAL; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; OXIDATIVE STRESS; PANTETHEINE; SCLERODERMA, SYSTEMIC; TREATMENT OUTCOME;

EID: 84933059389     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39121     Document Type: Article

References (34)

1. Gabrielli A, Avvedimento EV, Krieg T., Scleroderma. N Engl J Med 2009; 360: 1989-2003.
2. Pendergrass SA, Hayes E, Farina G, Lemaire R, Farber HW, Whitfield ML, et al., Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury. PLoS One 2010; 5: e12106.
3. Takahashi T, Kobayashi S, Fujino N, Suzuki T, Ota C, He M, et al., Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility. Thorax 2012; 67: 1067-74.
4. Santos MJ, Carmona-Fernandes D, Canhao H, Canas da Silva J, Fonseca JE, Gil V., Early vascular alterations in SLE and RA patients: a step towards understanding the associated cardiovascular risk. PLoS One 2012; 7: e44668.
5. Guiducci S, Distler JH, Jungel A, Huscher D, Huber LC, Michel BA, et al., The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. Arthritis Rheum 2008; 58: 2845-53.
6. Prescott RJ, Freemont AJ, Jones CJ, Hoyland J, Fielding P., Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol 1992; 166: 255-63.
7. Gabrielli A, Svegliati S, Moroncini G, Pomponio G, Santillo M, Avvedimento EV., Oxidative stress and the pathogenesis of scleroderma: the Murrell's hypothesis revisited. Semin Immunopathol 2008; 30: 329-37.
8. Casciola-Rosen L, Wigley F, Rosen A., Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis. J Exp Med 1997; 185: 71-9.
9. Servettaz A, Goulvestre C, Kavian N, Nicco C, Guilpain P, Chereau C, et al., Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse. J Immunol 2009; 182: 5855-64.
10. Rautou PE, Vion AC, Amabile N, Chironi G, Simon A, Tedgui A, et al., Microparticles, vascular function, and atherothrombosis. Circ Res 2011; 109: 593-606.
11. Sabatier F, Darmon P, Hugel B, Combes V, Sanmarco M, Velut JG, et al., Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 2002; 51: 2840-5.
12. Combes V, Coltel N, Faille D, Wassmer SC, Grau GE., Cerebral malaria: role of microparticles and platelets in alterations of the blood-brain barrier. Int J Parasitol 2006; 36: 541-6.
13. Distler JH, Huber LC, Gay S, Distler O, Pisetsky DS., Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity 2006; 39: 683-90.
14. Combes V, Coltel N, Alibert M, van Eck M, Raymond C, Juhan-Vague I, et al., ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology. Am J Pathol 2005; 166: 295-302.
15. Penet MF, Abou-Hamdan M, Coltel N, Cornille E, Grau GE, de Reggi M, et al., Protection against cerebral malaria by the low-molecular-weight thiol pantethine. Proc Natl Acad Sci U S A 2008; 105: 1321-6.
16. Gaddi A, Descovich GC, Noseda G, Fragiacomo C, Colombo L, Craveri A, et al., Controlled evaluation of pantethine, a natural hypolipidemic compound, in patients with different forms of hyperlipoproteinemia. Atherosclerosis 1984; 50: 73-83.
17. Prisco D, Rogasi PG, Matucci M, Paniccia R, Abbate R, Gensini GF, et al., Effect of oral treatment with pantethine on platelet and plasma phospholipids in IIa hyperlipoproteinemia. Angiology 1987; 38: 241-7.
18. Eto M, Watanabe K, Chonan N, Ishii K., Lowering effect of pantethine on plasma β-thromboglobulin and lipids in diabetes mellitus. Artery 1987; 15: 1-12.
19. Kavian N, Marut W, Servettaz A, Laude H, Nicco C, Chereau C, et al., Arsenic trioxide prevents murine sclerodermatous graft-versus-host disease. J Immunol 2012; 188: 5142-9.
20. Coriat R, Marut W, Leconte M, Ba LB, Vienne A, Chereau C, et al., The organotelluride catalyst LAB027 prevents colon cancer growth in the mice. Cell Death Dis 2011; 2: e191.
21. Servettaz A, Guilpain P, Goulvestre C, Chereau C, Hercend C, Nicco C, et al., Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis. Ann Rheum Dis 2007; 66: 1202-9.
22. Aebi H., Catalase in vitro. Methods Enzymol 1984; 105: 121-6.
23. Hamon Y, Broccardo C, Chambenoit O, Luciani MF, Toti F, Chaslin S, et al., ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat Cell Biol 2000; 2: 399-406.
24. Slyshenkov VS, Piwocka K, Sikora E, Wojtczak L., Pantothenic acid protects jurkat cells against ultraviolet light-induced apoptosis. Free Radic Biol Med 2001; 30: 1303-10.
25. Mostefai HA, Agouni A, Carusio N, Mastronardi ML, Heymes C, Henrion D, et al., Phosphatidylinositol 3-kinase and xanthine oxidase regulate nitric oxide and reactive oxygen species productions by apoptotic lymphocyte microparticles in endothelial cells. J Immunol 2008; 180: 5028-35.
26. Wittwer CT, Gahl WA, Butler JD, Zatz M, Thoene JG., Metabolism of pantethine in cystinosis. J Clin Invest 1985; 76: 1665-72.
27. Pitari G, Maurizi G, Ascenzi P, Ricci G, Dupre S. A kinetic study on pantetheinase inhibition by disulfides. Eur J Biochem 1994; 226: 81-6.
28. Kobayashi D, Kusama M, Onda M, Nakahata N., The effect of pantothenic acid deficiency on keratinocyte proliferation and the synthesis of keratinocyte growth factor and collagen in fibroblasts. J Pharmacol Sci 2011; 115: 230-4.
29. Mezentsev A, Merks RM, O'Riordan E, Chen J, Mendelev N, Goligorsky MS, et al., Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress. Am J Physiol Heart Circ Physiol 2005; 289: H1106-14.
30. Mostefai HA, Meziani F, Mastronardi ML, Agouni A, Heymes C, Sargentini C, et al., Circulating microparticles from patients with septic shock exert protective role in vascular function. Am J Respir Crit Care Med 2008; 178: 1148-55.
31. Agouni A, Lagrue-Lak-Hal AH, Ducluzeau PH, Mostefai HA, Draunet-Busson C, Leftheriotis G, et al., Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol 2008; 173: 1210-9.
32. Hiramatsu K, Nozaki H, Arimori S., Influence of pantethine on platelet volume, microviscosity, lipid composition and functions in diabetes mellitus with hyperlipidemia. Tokai J Exp Clin Med 1981; 6: 49-57.
33. Rana A, Seinen E, Siudeja K, Muntendam R, Srinivasan B, van der Want JJ, et al., Pantethine rescues a Drosophila model for pantothenate kinase-associated neurodegeneration. Proc Natl Acad Sci U S A 2010; 107: 6988-93.
34. Combes V, Simon AC, Grau GE, Arnoux D, Camoin L, Sabatier F, et al., In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999; 104: 93-102.